Clinical Trial

Mobilization and Outcomes After Venous Closure

Study acronym: MOVE
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this post-market registry is to collect real-world outcomes and evaluate usage practice of MYNX CONTROL™ VENOUS (MCV) Vascular Closure Device (VCD) 6F-12F in sealing femoral venous access sites in patients who have undergone endovascular procedures in a real-world setting.
Protocol Amendment History 2 changes
critical Enrollment closed, study ongoing 2026-08-11
notable Enrollment increased: 300 -> 339 participants 2026-08-11
Trial Details
NCT Number NCT07246902
Lead Sponsor Cordis US Corp.
Collaborators: NAMSA
Conditions Venous Vascular Closure, Electrophysiology Study
Enrollment 339 participants
Start Date 2025-11-24
Primary Completion 2026-08-21 (estimated)
Study Completion 2026-08-21 (estimated)
Updated on ClinicalTrials.gov 2026-08-10